Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
27.56
+0.44 (1.62%)
At close: Apr 14, 2026, 4:00 PM EDT
27.60
+0.04 (0.15%)
After-hours: Apr 14, 2026, 4:10 PM EDT
Oculis Holding AG Employees
Oculis Holding AG had 49 employees as of December 31, 2024. The number of employees increased by 13 or 36.11% compared to the previous year.
Employees
49
Change (1Y)
13
Growth (1Y)
36.11%
Revenue / Employee
$30,859
Profits / Employee
-$2,546,857
Market Cap
1.63B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 49 | 13 | 36.11% |
| Dec 31, 2023 | 36 | 8 | 28.57% |
| Dec 31, 2022 | 28 | - | - |
| Sep 30, 2022 | 32 | - | - |
| Jun 30, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Immunocore Holdings | 524 |
| Intellia Therapeutics | 377 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 298 |
| Harmony Biosciences Holdings | 293 |
| Viridian Therapeutics | 252 |
| Rapport Therapeutics | 84 |
OCS News
- 6 days ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewsWire
- 7 days ago - Oculis to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 14 days ago - Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis - GlobeNewsWire
- 4 weeks ago - Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting - GlobeNewsWire
- 5 weeks ago - Oculis Publishes 2025 Consolidated Financial Statements - GlobeNewsWire
- 6 weeks ago - Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update - GlobeNewsWire
- 7 weeks ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - GlobeNewsWire
- 2 months ago - Oculis Appoints Katie Kazem as Chief Legal Officer - GlobeNewsWire